Preliminary results of cross – Sectional research for moderate cognitive impairments among persons over 60 years in the Kazakh population

Abstract

Today, about two million elderly people live in Kazakhstan, which is more than 10% of the population, thus crossing the seven percent threshold for the definition of an “aging” country in the world. Data on the prevalence of mild cognitive impairment (MCI) and dementia are absent in Central Asia, particularly in Kazakhstan. The Global prevalence pattern of dementia depends on several factors, from life expectancy to the health status, last but not least from the particular environment. It is very difficult to determine a particular factor for it. To study the prevalence of cognitive impairment in persons of the Kazakh population over 60 years old in Almaty 150 respondents aged from 60 to 84 years (Mean age 67.6) took part in the screening. The material was collected using the Champ Clinic Questionnaire Questionnaire and the MOCA test (cut point <26) on the basis of the Almaty city polyclinic. Mild cognitive impairment was detected - 39.9%, light cognitive impairment - 33,4%, normal cognitive function - 26.7%. Expected risk factors for MCI: arterial hypertension – 86.89%, Cardiac ischemia, angina pectoris – 70.21%, pathology of the thyroid gland and pancreas (Diabetes, hyperthyroidism and hypothyroidism) – 29.50%, atherosclerotic vascular disease – 29.9%, brain trauma – 18.22%, level of education – 4.24%, depression – 0.6%, respectively. Kazakhstan is a middle-income country with a growing tendency of an aging population, and we have an urgent need to continue screening the population for the identification of moderate cognitive impairment in individuals in the Kazakh population.